Every Form 4 that Olaplex Holdings, Inc. (OLPX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OLPX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OLPX filings page.
Advent International-affiliated entities disposed of their entire reported stake in Olaplex Holdings through a tender offer. They tendered 499,468,771 shares of Common Stock at $2.06 per share in a disposition classified as pursuant to a tender offer, leaving 0 shares reported as beneficially owned after the transaction.
MORFITT MARTHA A M reported disposition transactions in this Form 4 filing.
Olaplex Holdings director Martha A. M. Morfitt fully exited her equity position as part of the company’s cash merger with Henkel US Operations Corporation. At the merger’s effective time, 411,833 shares of Common Stock held directly and by her spouse were converted into the right to receive $2.06 per share in cash.
In addition, 110,294 shares underlying her restricted stock unit awards were automatically cancelled and converted into a cash payment based on the same $2.06-per-share merger consideration. All 376,110 of her stock options, which had a $3.34 exercise price above the cash merger price, were cancelled for no consideration, leaving her with no remaining Olaplex equity or options.
OLAPLEX HOLDINGS, INC. insider filings show Advent International–affiliated entities reporting a full disposition of their indirect stake through a tender offer. The Form 4 lists a tender-offer disposition of 499,468,771 shares of common stock at $2.06 per share. Following this transaction, the reporting entities show 0 shares of Olaplex common stock held indirectly.
OLAPLEX HOLDINGS, INC. insider Kenneth F. Egan disposed of his common stock in connection with the company’s merger with Henkel US Operations Corporation. A total of 10,000 shares of common stock were transferred to the issuer at an effective price of $2.06 per share, leaving him with zero shares reported after the transaction.
Under the Agreement and Plan of Merger, each outstanding Olaplex common share was automatically converted at the effective time into the right to receive $2.06 in cash per share, and Olaplex became a wholly owned subsidiary of Henkel’s acquisition entity.
OLAPLEX HOLDINGS, INC. director and CEO Amanda Baldwin reported merger-related changes to her equity holdings. In connection with the merger in which Henkel US Operations Corporation acquired Olaplex, each share of common stock was converted into the right to receive $2.06 in cash at the effective time.
Baldwin disposed of 9,129,515 shares of common stock to the issuer at $2.06 per share and now reports no remaining common stock. Footnotes state that 7,910,624 shares underlying her restricted stock unit awards were automatically cancelled and converted into the right to receive the same cash merger consideration.
All 4,237,288 of her company stock options, which had a per-share exercise price of $2.53, were cancelled for no consideration because their exercise price exceeded the $2.06 merger price, leaving no remaining option holdings.
OLAPLEX HOLDINGS, INC. officer Catherine Dunleavy reported a full disposition of her equity in connection with the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, 3,026,885 shares of common stock were converted into the right to receive $2.06 per share in cash.
This total includes 2,705,329 shares underlying restricted stock unit awards that were automatically cancelled and converted into cash at the same $2.06 merger consideration. Following these transactions, Dunleavy held no Olaplex common shares.
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported dispositions tied to the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, his 971,384 common shares were converted into the right to receive $2.06 per share in cash.
The filing also notes 803,173 shares underlying his restricted stock units were cancelled and converted into the same cash consideration. In addition, 170,000 stock options with exercise prices of $5.41 and $14.95 per share were cancelled for no consideration, leaving him with no reported remaining shares or options.
OLAPLEX HOLDINGS, INC. director Jerome Griffith reported a disposition of common stock tied to the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, each Olaplex share was automatically converted into the right to receive $2.06 per share in cash.
The filing shows 110,294 shares underlying Griffith’s restricted stock unit awards were automatically cancelled and converted into the right to receive the same $2.06 per-share merger consideration. Following this cash-out transaction, the report shows Griffith with 0 shares of Olaplex common stock directly owned.
OLAPLEX HOLDINGS, INC. director Tricia Glynn reported dispositions of Common Stock in connection with the closing of a cash merger. At the merger’s effective time, each share of Olaplex Common Stock was automatically converted into the right to receive $2.06 in cash per share.
The filing shows 499,468,771 indirectly held shares, managed by various Advent International funds, and 248,693 directly held shares were disposed of to the issuer at $2.06 per share, leaving zero reported holdings. The reported amount also reflects 110,294 shares underlying restricted stock unit awards that were cancelled and converted into cash at the same $2.06 merger consideration.
OLAPLEX HOLDINGS, INC. director John P. Bilbrey reported dispositions of Common Stock in connection with the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, each share of Olaplex Common Stock was converted into the right to receive $2.06 in cash per share, subject to tax withholding.
The filing shows 318,418 shares held indirectly through the Amended and Restated John P. Bilbrey Revocable Declaration of Trust and 640,021 shares held directly were disposed of to the issuer at $2.06 per share, leaving zero reported shares in each category. In addition, 294,118 shares underlying Mr. Bilbrey’s restricted stock unit awards were cancelled and converted into cash based on the same $2.06 per-share merger consideration.
OLAPLEX HOLDINGS, INC. director David M. Mussafer reported a full disposition of his indirect and direct holdings in connection with the company’s cash merger with Henkel US Operations Corporation. At the merger’s effective time, each common share was converted into the right to receive $2.06 in cash, without interest, subject to withholding taxes.
The filing shows an indirect disposition of 499,468,771 common shares and a direct disposition of 248,693 common shares, both labeled as dispositions to the issuer under the merger agreement. The indirect shares were held by various funds and accounts managed directly and indirectly by Advent International, L.P., where Mussafer is Chairman and Managing Partner, and he disclaims beneficial ownership beyond any pecuniary interest. Following these transactions, the report shows zero shares owned directly or indirectly. Footnotes also state that 110,294 shares underlying his restricted stock unit awards were cancelled and converted into the same cash merger consideration.
OLAPLEX HOLDINGS, INC. director Christine Dagousset reported disposing of her entire equity position in connection with the company’s merger. Each common share was converted into the right to receive $2.06 in cash at the merger’s effective time.
Dagousset’s Form 4 shows 254,483 shares of common stock disposed of to the issuer and all 506,250 company stock options cancelled and converted into cash. The options had a per-share exercise price of $0.76, so each was converted into $1.30 in cash, the excess of the merger price over the strike. Footnotes also note 110,294 shares underlying RSU awards were cancelled for cash, leaving her with zero reported shares and options afterward.
OLAPLEX HOLDINGS, INC. reported that investment entities associated with Advent International disposed of 499,468,771 shares of Common Stock in a single transaction. The shares were transferred on July 7, 2026 pursuant to a tender offer at a price of $2.06 per share.
Following this tender-offer disposition, the reporting entities list 0 shares of Olaplex Common Stock as indirectly owned in this filing, indicating a complete exit of the position reported here.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported a merger-related disposition of 1,064,039 shares of common stock back to the company. The transaction used code D, indicating a disposition to the issuer rather than an open‑market sale.
Under the merger with Henkel US Operations Corporation, each share of Olaplex common stock was automatically converted into the right to receive $2.06 in cash per share. The reported amount includes 830,151 shares underlying Fox’s restricted stock unit awards, which were cancelled and converted into cash at the same merger consideration. Following the transaction, Fox reported holding zero shares of Olaplex common stock.
OLAPLEX HOLDINGS, INC. director Pamela J. Edwards reported a disposition of common stock in connection with the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, 110,294 shares underlying her restricted stock unit awards were automatically cancelled and converted into cash at $2.06 per share, matching the cash merger consideration paid for each outstanding Olaplex share. Following this cash-out, the filing shows she no longer holds Olaplex common stock or related equity awards.
OLAPLEX HOLDINGS, INC. completed a cash merger in which each share of its common stock was automatically converted into the right to receive $2.06 per share in cash at the merger’s effective time. Director Michael James White reported dispositions to the issuer of 499,468,771 indirectly held shares managed by Advent-related funds and 248,693 directly held shares, leaving no remaining common stock. In addition, 110,294 shares underlying his restricted stock unit awards were cancelled and converted into the same cash merger consideration.
Findlay Deirdre reported disposition transactions in this Form 4 filing.
OLAPLEX HOLDINGS, INC. director Deirdre Findlay reported that all of her equity in the company was cashed out in connection with a completed merger with Henkel US Operations Corporation. At the merger’s effective time, 248,693 shares of common stock were converted into the right to receive $2.06 per share in cash, and her resulting common stock holdings fell to zero.
Her equity awards were also cancelled for cash. 110,294 shares underlying restricted stock unit awards were converted into cash at the same $2.06 per-share merger consideration. In addition, 506,250 stock options with a per-share exercise price of $1.65 were cancelled and converted into $0.41 per underlying share in cash, representing the excess of the merger price over the exercise price. Following these transactions, the filing shows no remaining options or shares for the reporting person.
OLAPLEX HOLDINGS, INC. director-associated entities and awards were cashed out in connection with a merger. Under an Agreement and Plan of Merger, each share of common stock was converted at the effective time into the right to receive $2.06 per share in cash, described as the Merger Consideration. Restricted stock units covering 110,294 shares held for Emily White were automatically cancelled and converted into a cash right based on this same per-share amount. Additional common shares were disposed of to the issuer at $2.06 per share from entities including Anthos Capital IV, L.P., Anthos Tribe, L.P., and Anthos Management LP, which are managed by affiliates of her spouse; she disclaims beneficial ownership of those shares except for any pecuniary interest.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported an open-market sale of 16,324 shares of common stock at $2.04 per share. According to the filing, this "sell to cover" transaction was required to satisfy tax withholding obligations from vesting restricted stock units. After the sale, she continues to directly hold 1,064,039 shares, indicating the transaction was a small, tax-driven adjustment rather than a change in her overall equity position.
Olaplex Holdings, Inc. General Counsel John C. Duffy reported an open-market sale of 11,471 shares of common stock at $2.02 per share. According to the footnote, this was a required “sell to cover” transaction to satisfy tax withholding on vested restricted stock units.
After the sale, Duffy directly owned 971,384 shares of Olaplex common stock. Because the sale was driven by tax obligations tied to RSU vesting rather than a discretionary trade, it reflects a routine compensation-related activity rather than a change in investment stance.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported a sale of common stock tied to tax obligations. On this Form 4, she sold 25,421 shares at $1.26 per share in a “sell to cover” transaction required to satisfy tax withholding from vesting restricted stock units. After the transaction, she held 1,080,363 common shares directly.
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported an open-market sale of 34,962 shares of common stock at $1.26 per share. According to the footnote, this was a required "sell to cover" transaction to satisfy tax withholding obligations on vesting restricted stock units. After the sale, Duffy directly held 982,855 shares, indicating he retained a substantial equity position in the company.
Olaplex Holdings, Inc. COO and CFO Catherine Dunleavy reported an open-market sale of 93,809 shares of common stock at $1.26 per share. According to the filing, the shares were sold solely to cover tax withholding obligations tied to the vesting of restricted stock units through a “sell to cover” transaction under the applicable RSU award agreement.
After this tax-related sale, Dunleavy directly holds 3,026,885 shares of Olaplex common stock. The transaction reflects a mechanistic step associated with equity compensation rather than a discretionary change in her investment position.
OLAPLEX HOLDINGS, INC. Chief Executive Officer Amanda Baldwin reported an open-market sale of 451,837 shares of common stock at $1.17 per share. According to the filing, this sale was required to cover tax withholding obligations tied to the vesting of restricted stock units through a “sell to cover” transaction.
After this tax-related sale, Baldwin directly holds 9,129,515 shares of common stock. Because the transaction was executed solely to satisfy tax obligations under the RSU award agreement, it reflects a routine administrative event rather than a discretionary change in investment exposure.
OLAPLEX HOLDINGS, INC. Chief People Officer Trisha L. Fox reported both a share sale and a large equity award. She sold 26,426 shares of Common Stock at $1.26 per share on March 9, 2026 to cover tax withholding obligations from vesting restricted stock units through a sell-to-cover transaction. On March 10, 2026, she was granted 384,615 RSUs under the 2021 Equity Incentive Plan, which vest in four equal annual installments from March 10, 2027 through March 10, 2030, subject to continued employment. Following these transactions, she directly holds 1,105,784 shares of Common Stock. The filing also notes an earlier transfer of 15,625 shares to her ex-spouse pursuant to a domestic relations order.
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported both a stock sale and a new equity award. On March 9, 2026, he sold 34,824 shares of common stock at $1.26 per share in a sell-to-cover transaction to satisfy tax withholding obligations tied to vesting restricted stock units (RSUs).
On March 10, 2026, he received a new grant of 384,615 RSUs under the 2021 Equity Incentive Plan, with each unit representing one future share of common stock. These RSUs vest in four equal installments on March 10, 2027, 2028, 2029, and 2030, contingent on continued employment. After these transactions, he directly holds 1,017,817 shares of common stock.
DUNLEAVY CATHERINE reported acquisition or exercise transactions in this Form 4 filing.
OLAPLEX HOLDINGS, INC. reported that its COO and CFO, Catherine Dunleavy, received a grant of 1,153,846 shares of Common Stock in the form of restricted stock units under the company’s 2021 Equity Incentive Plan. After this award, she holds 3,120,694 shares directly.
The RSUs carry no purchase price and each unit represents the right to receive one share of common stock. They will vest in four equal installments on March 10 of 2027, 2028, 2029 and 2030, contingent on her continued employment with the company through each vesting date.
Baldwin Amanda reported acquisition or exercise transactions in this Form 4 filing.
Olaplex Holdings, Inc. reported that Chief Executive Officer Amanda Baldwin received a grant of 3,846,154 restricted stock units (RSUs) under the company’s 2021 Equity Incentive Plan. Each RSU represents one share of common stock and vests in four equal annual installments from March 10, 2027 through March 10, 2030, contingent on her continued employment. Following this award, she directly holds 9,581,352 shares of common stock, aligning a substantial portion of her compensation with the company’s future performance.
Olaplex Holdings, Inc. disclosed that its chief executive officer and director reported a sale of 398,560 shares of common stock on December 12, 2025. The transaction, coded as a sale, was executed at a price of $1.19 per share.
According to the filing, these shares were sold to cover tax withholding obligations arising from the vesting of restricted stock units through a "sell to cover" transaction under the applicable RSU award agreement. After this transaction, the reporting person beneficially owns 5,735,198 shares of Olaplex common stock directly.